WST · West Pharmaceutical Services, Inc.

Healthcare NYQ United States westpharma.com ↗
Val Gro Qua Mom Sta Cap P/S7.32 P/E Fwd P/E34.70 PEG2.62 52W –  RSI Target$405.38 (+17.1%) Beta1.14 Div0.25%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Instruments & Supplies Exton, United States 10,800 employees
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 51 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
4Bullish
5Bearish
0Neutral

Key Signals 1

▼ Double Top Major reversal 2026-08-28 · $343.48
Two peaks ~$359.48 — bearish reversal confirmed
Learn more →

Momentum Signals 8

▲ MACD Bullish Crossover 2026-06-10 · $330.7
▲ Bull Flag 2026-06-24 · $336.6
▲ Bull Flag 2026-07-16 · $360.84
▲ MACD Bullish Crossover 2026-08-07 · $354.07

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Oct 22, 2026
Beat Rate 100%
Consensus STRONG BUY
Analyst Upside +17.1%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
STRONG BUY
15
2
BuyHoldSell
Price Target Range
$405.38 +17.1% upside
Low $340 High $459
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 36.79%Last 12 Months
Operating Margin 22.47%Last 12 Months
Return on Equity 19.09%Last 12 Months
Revenue Growth 13.80%Year over Year
Free Cash Flow 277.94MLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 10.59Most Recent Quarter
Current Ratio 2.82Most Recent Quarter
Cash 435.80MMost Recent Quarter
Total Debt 316.50MMost Recent Quarter
Net Debt Most Recent Quarter
How WST Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap24.37B
Enterprise Value24.25B
Trailing P/E44.05
Forward P/E34.70
PEG Ratio (5yr)2.62
Price/Sales (ttm)7.32
Price/Book (mrq)8.15
EV/Revenue7.29
EV/EBITDA26.58
Share Statistics
Avg Vol (3m)691.32K
Shares Outstanding70.38M
Float69.86M
% Held by Insiders0.64%
% Held by Institutions101.96%
Short Ratio4.33
Short % of Float3.65%
Profitability
Gross Margin36.79%
Operating Margin (ttm)22.47%
Profit Margin16.98%
Return on Assets (ttm)11.38%
Return on Equity (ttm)19.09%
Income Statement
Revenue (ttm)3.33B
Revenue Growth (yoy)13.80%
Gross Profit (ttm)1.22B
EBITDA912.20M
Net Income (ttm)564.90M
Diluted EPS (ttm)7.86
EPS Growth (yoy)18.10%
Balance Sheet
Total Cash (mrq)435.80M
Total Debt (mrq)316.50M
Debt / Equity (mrq)10.59
Current Ratio (mrq)2.82
Book Value / Share42.47
Operating CF (ttm)662.20M
Free Cash Flow (ttm)277.94M
Trading & Dividends
Beta (5Y)1.14
50-Day MA349.21
200-Day MA294.94
Fwd Dividend Yield0.26%
Payout Ratio11.14%
Income
Dividend Yield 0.25%Last 12 Months
Annual Rate 0.88Forward
Payout Ratio 11.14%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 11.14%
Monthly Dividends
Ownership Breakdown
Institutional 101.96% Insider 0.64%
Short Interest 3.65% of float
Moderate
Institutional 13F Holdings

Famous investors who disclosed a position in WST in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value